4478 JPX Week ended 31 Jul 2026

Weekly Investor Report

freee K.K. · Technology · Software - Application

Open interactive chart View report data
Latest close 2,599 JPY
8.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 13.6% above the Trend Line and sits at 30.7% of its 52-week range. The latest completed week returned 8.1%, after a 22.4% four-week move. The latest news-sentiment score is 54/100.

Setup score 42 out of 100
Latest Close 2,599 JPY 31 Jul 2026
1W Return 8.1% latest completed week
4W Return 22.4% short-term follow-through
12W Return 6.7% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 8.1% Latest completed week; four-week move 22.4%. Indicator stack 2/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 13.6% above the Trend Line and sits at 30.7% of its 52-week range. The latest completed week returned 8.1%, after a 22.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 22.4% over four weeks, 6.7% over 12 weeks, and -38.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W8.1%
4W22.4%
12W6.7%
26W-4.1%
52W-38.0%
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.17Latest activity-pressure read.
Pressure change3986.6%Four-week change in activity pressure.
Leadership-22.62Latest relative-leadership reading.
RS change51.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 3 relevant articles.

1 positive · 2 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.0%Distance below the 52-week high.
13-week volatility7.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+24.6%Week of 17 Apr.
Worst week-17.2%Week of 13 Mar.
Latest week+8.1%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains3
Flat weeks0
Modest losses3
Sharp losses10
Recent vol7.8%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew6.7% / -6.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape33/100

Trend, activity pressure, participation, and risk combine to a 33/100 tape read.

 Indicator analysis28/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment54/100

Weighted news tone is neutral across 3 relevant articles.

freee K.K. Revenue Breakdown – TSE:4478 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262,599 JPY8.1%2,287 JPY2,984 JPY1.17-22.622.7MOff
24 Jul 20262,405 JPY-0.1%2,300 JPY2,988 JPY0.89-30.281.5MOff
17 Jul 20262,407 JPY7.0%2,322 JPY2,992 JPY0.54-31.232.3MOff
10 Jul 20262,250 JPY5.9%2,341 JPY2,997 JPY0.23-41.101.6MOff
3 Jul 20262,124 JPY13.2%2,364 JPY3,003 JPY-0.03-46.473.2MOff
26 Jun 20261,876 JPY-5.9%2,393 JPY3,009 JPY-0.09-53.38314.0KOff
19 Jun 20261,993 JPY7.6%2,430 JPY3,018 JPY0.08-52.81385.0KOff
12 Jun 20261,853 JPY-14.0%2,469 JPY3,026 JPY0.22-53.70650.2KOff
5 Jun 20262,155 JPY2.0%2,524 JPY3,037 JPY0.48-47.72256.5KOff
29 May 20262,112 JPY-6.0%2,561 JPY3,044 JPY0.54-49.663.0MOff
22 May 20262,246 JPY2.9%2,606 JPY3,052 JPY0.48-45.003.4MOff
15 May 20262,182 JPY-10.4%2,647 JPY3,059 JPY0.45-45.914.3MOff
8 May 20262,435 JPY7.1%2,687 JPY3,069 JPY0.40-42.031.3MOff
1 May 20262,274 JPY-0.3%2,727 JPY3,078 JPY0.02-44.082.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.